Abstract
Isogenic mouse strains have previously been characterized as susceptible or resistant to Paracoccidioides brasiliensis infection; the former presented anergy in delayed-type hypersensitivity reactions (DTH) and progressive disease with high numbers of colony-forming units (CFU), while the later presented preserved DTH responses and control of the infectious process. Here, we studied whether susceptible mice infected with P. brasiliensis and treated with the antifungal drug trimethoprim-sulfamethoxazole (SXT) had their behavior pattern altered to the one observed in infected resistant mice. Therapy with either 30 or 150 mg SXT day−1 kg−1, instituted 24 h after infection, elicited more adequate DTH responses than those of non-treated mice, and also diminished the number of viable fungi in the spleen and lungs, but not in epiploo and liver, indicating a partial control of the infectious process. This phenomenon was confirmed by histopathological analyses, in which the spleen was found to be the organ in which differences between the treated and non-treated groups were most remarkable. In control non-treated mice, the spleen parenchyma showed multiple granulomatous foci presenting giant cells, plasmocytes and many yeasts of P. brasiliensis with well-preserved morphology and abundant budding, whereas SXT-treated mice, independently of the dosage used, had no granulomas within the parenchyma and only few capsular lesions, mainly composed of pseudoxantomatous macrophages. Treatment with 150 mg day−1 kg−1 (the dose considered to evoke best responses in CFU assays when therapy was instituted 24 h after infection), initiated at different times after infection, did not led to sustained DTH reactions, but provided an effective control of the disease when therapy began until the 15th day post infection, as showed by CFU assays. We conclude that reversal from the susceptible to the resistant pattern in experimental paracoccidioidomycosis can occur, but only when therapy with an adequate SXT dosage is instituted at a very initial phase of the infection. These protocols may constitute a model for further investigations concerning responses during antifungal therapy.
Similar content being viewed by others
References
Bagioni L, Souza MJ, Chamma LG, Mendes RP, Marques SA, Mota NGS, Franco M (1984) Correlation between class-specific antibodies and clinical forms of the disease. Trans R Soc Trop Med Hyg 78:617
Berliner MD, Reca ME (1966) Vital staining of Histoplasma capsulatum with Janus Green B. Sabouraudia 5:26–29
Calich VLG, Singer-Vermes LM, Siqueira AM, Burger E. (1985) Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br J Exp Pathol 66:585–594
Calich VLG, Vaz CAC, Burger E (1998) Immunity to Paracoccidioides brasiliensis infection. Res Immunol 149:407–417
Carson FL, Martin JH, Lynn JA (1973) Formallin fixation for electron microscopy: a re-evaluation. Am J Clin Pathol 59:365–373
Castañeda E., Brumer E, Perlman AM, McEvens J, Stevens DA (1988) A culture medium for P. brasiliensis with high plating efficiency and the effect of siderophores. J Med Vet Mycol 26:351–58
Clemons KV, Stevens DA (2000) Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-γ. Med Mycol 38:213–219
Clemons KV, Lutz JE, Stevens DA (2001) Efficacy of interferon-γ and amphotericin B for the treatment of systemic murine histoplasmosis. Microbes Infect 3:3–10
Fava Netto C (1955) Estudos quantitativos sobre a fixação do complemento na blastomicose sul-americana, com antígeno polissacarídico. Arq Cir Clin Exp Sao Paulo 18:197–254
Fava Netto C, Vegas VS, Sciannaméa IM, Guarnieri EDB. (1969) Antígeno polissacarídico do Paracoccidioides brasiliensis. Estudo do tempo de cultivo do P. brasiliensis para o preparo do antígeno. Rev Inst Med Trop São Paulo 11:117–181
Fazioli RA, Singer-Vermes LM, Kashino SS, Calich VLG (1986) Standardization of the intradermal test in experimental murine paracoccidioidomycosis. Braz J Med Biol Res, 19:641A
Fazioli RA, Singer-Vermes LM, Kashino SS, Burger E, De Franco MF, Moscardi-Bacchi M, Calich VLG (1994) Delayed-type hypersensitivity response in an isogenic murine model of paracoccidioidomycosis. Mycopathologia 126:137–416
Franco M, Bagagli E, Scapolio S, Lacaz CS (2000) A critical analysis of isolation of Paracoccidioides brasiliensis from soil. Med Mycol 38:185–191
Kashino, SS, Singer-Vermes LM, Calich VLG, Burger E (1990) Alterations in the pathogenicity of one Paracoccidioides brasiliensis isolate do not correlate with its in vivo growth. Mycopathologia 111:173–180
Kashino SS, Fazioli RA, Cafalli-Favati C, Meloni-Bruneri LH, Vaz CAC, Burger E, Singer LM, Calich VLG (2000) Resistance to Paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with absence of IFN-γ production. J. Interferon Cytokine Res 20:89–97
Labro MT (2000) Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev 13:615–650
Mendes RP (1994) The gamut of clinical manifestations. In: Franco MF, Lacaz CS, Restrepo-Moreno A, Del Negro G (eds) Paracoccidioidomycosis. CRC Press, Boca Raton, pp 233–258
Mendes RP, Negroni R, Arechavala A (1994) Treatment and control of cure. In: Franco MF, Lacaz CS, Restrepo-Moreno A, Del Negro G (eds) Paracoccidioidomycosis. CRC Press, Boca Raton, pp 373–392
Mota NGS, Rezkallah-Iwasso MT, Peraçoli MTS, Audi RC, Mendes RP, Marcondes J, Marques AS, Dillon NL, Franco MF (1985) Correlation between cell-mediated immunity and clinical forms of paracoccidioidomycosis. Trans R Soc Trop Med Hyg 79:765
Musatti CC, Peraçoli MTS, Soares AMVC, Rezkallah-Iwasso MT (1994) Cell-mediated immunity in patients with paracoccidioidomycosis. In: Franco MF, Lacaz CS, Restrepo-Moreno A, Del Negro G (eds) Paracoccidioidomycosis. CRC Press, Boca Raton, pp 175–186
Singer-Vermes LM, Burger E, Franco MF, Moscardi-Bacchi M, Mendes-Giannini MJS, Calich VLG (1989) Evaluation of the pathogenicity and immunogenicity of seven Paracoccidioides brasiliensis isolates in susceptible inbred mice. J Med Vet Mycol 27:71
Singer-Vermes LM, Ciavaglia MC, Kashino SS, Burger E, Calich VLG (1992) The source of the growth promoting factor affects the platting efficiency of P. brasiliensis. J Med Vet Mycol 30:261–264
Wanke B, Londero AT (1994) Epidemiology and paracoccidioidomycosis infection. In: Franco MF, Lacaz CS, Restrepo-Moreno A, Del Negro G (eds) Paracoccidioidomycosis. CRC Press, Boca Raton, pp 109–120
Xidieh CF, Lenzi HL, Calich VLG, Burger E (1999). Influence of the genetic background on the pattern of lesions developed by resistant and susceptible mice infected with Paracoccidioides brasiliensis. Med Microbiol Immunol 188:41–49
Zar TH (1984) Bioestatistical analysis, 2nd edn. Prentice Hall, Englewoods Cliffs, pp 150–165
Acknowledgements
This work was supported by FAPESP (Grant 96/05335-3) and CNPq (Grant 524520/96-8). R. Scavone held a fellowship (Grant 114446/96-2) from CNPq. The authors thank Dr. R.P. Mendes and Dr. G. Bernard for fruitful discussions, C.S. Cunha, A.S. Nishikaku and B.P. Albe for technical assistance and Dr. C.F. Xidieh for assistance in histopathological analyses.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scavone, R., Burger, E. Paracoccidioidomycosis: reduction in fungal load and abrogation of delayed-type hypersensitivity anergy in susceptible inbred mice submitted to therapy with trimethoprim-sulfamethoxazole. Med Microbiol Immunol 193, 53–59 (2004). https://doi.org/10.1007/s00430-003-0185-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-003-0185-y